Research

Energy balance

Patients switching from semaglutide due to plateau lost 8.1% TBW versus 2.9% for non-responders (p < 0.001).

Switching from semaglutide may yield different weight loss results based on prior response.

StrongSupportsmedium confidence
Those switching at a plateau (n = 28) lost 8.1% versus 2.9% for non-responders (n = 33; p < 0.001).
Sarah R. Barenbaum et al. · Obesity · 2026

Why this rating

Based on the retrospective cohort study design.

Source

Real‐World Weight‐Loss Outcomes in Weight‐Reduced Patients Treated With Tirzepatide

Sarah R. Barenbaum et al. · Obesity · 2026

DOI 10.1002/oby.70179

cohort · n=293Cited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →